4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0000950170-25-009256
Options or other derivatives
- Chief Legal Officer acquired 230,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kearns Evan Chief Legal Officer | 2025-01-23 | Grant or award · Stock Option (Right to Buy) | +230,000 | 230,000 | D | ||
Loading xslF345X05/ownership.xml…